Relapse free survival (RFS) at 3 years by pathological (path) response to neoadjuvant systemic treatment (NST) in patients (pts) with surgically resectable, high-risk melanoma Meeting Abstract
| Authors: | Burton, E.; Milton, D.; Simpson, L.; Tetzlaff, M.; Glitza, I. C.; Ross, M. I.; Gershenwald, J. E.; McQuade, J.; Wong, M.; Patel, S.; Diab, A.; Postow, M.; Ariyan, C. E.; Lee, J.; Fisher, S.; Prieto, V.; Davies, M.; Tawbi, H. A.; Wargo, J.; Amaria, R. |
| Abstract Title: | Relapse free survival (RFS) at 3 years by pathological (path) response to neoadjuvant systemic treatment (NST) in patients (pts) with surgically resectable, high-risk melanoma |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S659 |
| Language: | English |
| ACCESSION: | WOS:001087480201423 |
| DOI: | 10.1016/j.annonc.2023.09.2228 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1094P -- Source: Wos |
